Idenix Pharmaceuticals to Present at the 2008 Thomas Weisel Healthcare Conference
August 26 2008 - 8:00AM
PR Newswire (US)
CAMBRIDGE, Mass., Aug. 26 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix
management will present a corporate overview at the 2008 Thomas
Weisel Healthcare Conference on Thursday, September 4, 2008 at 1:30
p.m. ET at The Four Seasons Hotel in Boston, MA. The live and
archived webcast of the company presentation can be accessed under
"Calendar of Events" in the Idenix Investor Center at
http://www.idenix.com/. Please log in approximately 5-10 minutes
before each event to ensure a timely connection. The archived
replays will be available on the Idenix website for two weeks
following the conference. About Idenix Idenix Pharmaceuticals,
Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral and other infectious
diseases. Idenix's current focus is on the treatment of infections
caused by the hepatitis C virus and HIV. For further information
about Idenix, please refer to http://www.idenix.com/. Idenix
Pharmaceuticals Contacts: Amy Sullivan 617-995-9838 (investors)
Teri Dahlman 617-995-9905 (media) DATASOURCE: Idenix
Pharmaceuticals, Inc. CONTACT: Investors, Amy Sullivan,
+1-617-995-9838, or Media, Teri Dahlman, +1-617-995-9905, both of
Idenix Pharmaceuticals, Inc. Web site: http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024